BridgeMD
New treatment option for Propionibacterium Infection
Official title Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery
ClinicalTrials.gov ID: NCT02996656
What this study is testing
What is Cefazolin?
Cefazolin is an investigational medicine, being studied as a potential treatment for propionibacterium infection.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- INESS Antibiotic Prophylaxis in Orthopedic Guide recommends the use of Cefazolin at induction for all orthopaedic procedure with implantation of internal fixation device. With the increasing rate of identified P.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years and older
- Male or female
- Presenting normal skin on the shoulder aria
You likely can't join if
- Used antibiotics or treated their skin with antibiotic gel, alcohol gel or cream or acne treatment in the last three months
- Active infection at the surgical site or anywhere
- Affected shoulder previously received radiotherapy
- Allergic to one of the antimicrobial prophylaxis used
- Open fracture
- Life threatening or a limb threatening pathology
See the full eligibility criteria
- 18 years and older
- Male or female
- Presenting normal skin on the shoulder aria
- Used antibiotics or treated their skin with antibiotic gel, alcohol gel or cream or acne treatment in the last three months
- Active infection at the surgical site or anywhere
- Affected shoulder previously received radiotherapy
- Allergic to one of the antimicrobial prophylaxis used
- Open fracture
- Life threatening or a limb threatening pathology
- Liver or kidney failure
The study team makes the final eligibility decision.
Where it's taking place
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montreal, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.